RAIMY AMASHA: Open Payments
NPI 1760643498 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 80 payments from 16 companies in 2025. Trend: 2023 $2,836 · 2024 $2,172 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $587 |
| Spinal Simplicity, LLC | 28 | $524 |
| Medtronic, Inc. | 10 | $252 |
| Collegium Pharmaceutical, Inc. | 9 | $182 |
| Lundbeck LLC | 3 | $83 |
| ABBVIE INC. | 3 | $61 |
| Boston Scientific Corporation | 2 | $57 |
| Valinor Pharma, LLC | 2 | $42 |
| SPR Therapeutics, Inc | 1 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
Products named: PROCLAIM, HA MINUTEMAN G3-R, VANTA ADAPTIVESTIM, Belbuca, VYEPTI, Intracept, QULIPTA, MOVANTIK.
Industry payments across TX — which companies pay providers there.
